These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23981665)

  • 1. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
    Kang BS; Moon HJ; Kim YS; Lee ST; Jung KH; Chu K; Lee SK
    Epileptic Disord; 2013 Sep; 15(3):302-10. PubMed ID: 23981665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam: a long-term follow-up study of efficacy and safety.
    Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG
    Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study.
    Werhahn KJ; Klimpe S; Balkaya S; Trinka E; Krämer G
    Seizure; 2011 May; 20(4):305-11. PubMed ID: 21257324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.
    Grosso S; Franzoni E; Coppola G; Iannetti P; Verrotti A; Cordelli DM; Marchiani V; Pascotto A; Spalice A; Acampora B; Morgese G; Balestri P
    Seizure; 2005 Jun; 14(4):248-53. PubMed ID: 15911359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
    Goldberg-Stern H; Feldman L; Eidlitz-Markus T; Kramer U; Perez S; Pollak L; Phatal-Valevski A
    Eur J Paediatr Neurol; 2013 May; 17(3):248-53. PubMed ID: 23159714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
    Droz-Perroteau C; Marchal C; Dureau-Pournin C; Lassalle R; Jové J; Robinson P; Lavernhe G; Vespignani H; Moore N; Fourrier-Réglat A;
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1183-9. PubMed ID: 22972760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
    Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
    Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam as add-on therapy in generalised epilepsies.
    Kumar SP; Smith PE
    Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
    Lee YJ; Kang HC; Kim HD; Lee JS
    Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands.
    Lambrechts DA; Sadzot B; van Paesschen W; van Leusden JA; Carpay J; Bourgeois P; Urbain E; Boon PA
    Seizure; 2006 Sep; 15(6):434-42. PubMed ID: 16893660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up.
    Kuba R; Novotná I; Brázdil M; Kocvarová J; Tyrlíková I; Mastík J; Rektor I
    Acta Neurol Scand; 2010 Feb; 121(2):83-8. PubMed ID: 20003081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
    Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
    Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in refractory epilepsy: a prospective observational study.
    Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
    Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with levetiracetam for adults with epilepsy].
    Barcs G; Szucs A
    Ideggyogy Sz; 2007 Jan; 60(1-2):31-4. PubMed ID: 17432091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.